Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
49
SRI Quote, Financials, Valuation and Earnings
Last price:
$6.95
Seasonality move
:
-4.16%
Day range:
$6.97 - $7.28
52-week range:
$3.54 - $18.40
Dividend yield:
0%
P/E ratio:
204.86x
P/S ratio:
0.22x
P/B ratio:
0.79x
Volume:
227.3K
Avg. volume:
440.4K
1-year change:
-58.89%
Market cap:
$198.8M
Revenue:
$908.3M
EPS (TTM):
-$0.64
Analysts' Opinion
-
Consensus RatingStoneridge has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $14.00, Stoneridge has an estimated upside of 96.08% from its current price of $7.14.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $12.00 representing 100% downside risk from its current price of $7.14.
Fair Value
-
According to the consensus of 1 analyst, Stoneridge has 96.08% upside to fair value with a price target of $14.00 per share.
SRI vs. S&P 500
-
Over the past 5 trading days, Stoneridge has underperformed the S&P 500 by -12.66% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Stoneridge does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Stoneridge revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Stoneridge reported revenues of $217.9M.
Earnings Growth
-
Stoneridge has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Stoneridge reported earnings per share of -$0.26.
Enterprise value:
322.9M
EV / Invested capital:
--
Price / LTM sales:
0.22x
EV / EBIT:
879.84x
EV / Revenue:
0.36x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
12.94x
Price / Operating cash flow:
7.92x
Enterprise value / EBITDA:
9.48x
Gross Profit (TTM):
$187.2M
Return On Assets:
-2.68%
Net Income Margin (TTM):
-1.98%
Return On Equity:
-6.68%
Return On Invested Capital:
-3.82%
Operating Margin:
-1.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $920.2M | $973.7M | $887M | $239.2M | $217.9M | |
| Gross Profit | $176.3M | $206.9M | $187.2M | $48.4M | $46.3M | |
| Operating Income | $1.9M | $17.2M | -$3.9M | $331K | -$3.2M | |
| EBITDA | $29.5M | $49.6M | $34.1M | $6.8M | $5M | |
| Diluted EPS | -$0.51 | -$0.14 | -$0.64 | -$0.22 | -$0.26 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $343.1M | $396.3M | $423.1M | $431.3M | $418M | |
| Total Assets | $621.5M | $650.8M | $670.7M | $675.4M | $657.4M | |
| Current Liabilities | $144.7M | $179M | $202M | $180.2M | $175.2M | |
| Total Liabilities | $336.8M | $356.9M | $394.5M | $398.2M | $404.3M | |
| Total Equity | $284.7M | $293.9M | $276.2M | $277.3M | $253.1M | |
| Total Debt | $158.7M | $152.9M | $168.8M | $196.5M | $203.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $17.4M | $23.2M | $49.5M | $9.1M | $10.9M | |
| Cash From Investing | -$30.1M | -$33.9M | -$24.7M | -$5.7M | -$6M | |
| Cash From Financing | $7.7M | $25M | $4.9M | $5.4M | -$787K | |
| Free Cash Flow | -$16.9M | -$10.9M | $25M | $3.3M | $4.8M | |
SRI
Sector
Market Cap
$198.8M
$426.2M
Price % of 52-Week High
38.8%
73.88%
Dividend Yield
0%
0%
Shareholder Yield
-1.52%
4%
1-Year Price Total Return
-58.9%
-11.07%
Beta (5-Year)
1.420
0.767
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.57
200-day SMA
Buy
Level
$6.17
Bollinger Bands (100)
Buy
Level
4.09 - 6.37
Chaikin Money Flow
Sell
Level
-493.2K
20-day SMA
Buy
Level
$7.03
Relative Strength Index (RSI14)
Buy
Level
56.17
ADX Line
Sell
Level
14.93
Williams %R
Neutral
Level
-61.9666
50-day SMA
Buy
Level
$5.92
MACD (12, 26)
Buy
Level
2.00
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
355.1K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.6067)
Sell
CA Score
(Annual)
Level (-0.3261)
Buy
Beneish M-Score
(Annual)
Level (-3.1444)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (0.5738)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.
Stock Forecast FAQ
In the current month, SRI has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SRI average analyst price target in the past 3 months is $14.00.
-
Where Will Stoneridge Stock Be In 1 Year?
According to analysts, the consensus estimate is that Stoneridge share price will rise to $14.00 per share over the next 12 months.
-
What Do Analysts Say About Stoneridge?
Analysts are divided on their view about Stoneridge share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Stoneridge is a Sell and believe this share price will drop from its current level to $12.00.
-
What Is Stoneridge's Price Target?
The price target for Stoneridge over the next 1-year time period is forecast to be $14.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SRI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Stoneridge is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of SRI?
You can purchase shares of Stoneridge via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Stoneridge shares.
-
What Is The Stoneridge Share Price Today?
Stoneridge was last trading at $6.95 per share. This represents the most recent stock quote for Stoneridge. Yesterday, Stoneridge closed at $7.14 per share.
-
How To Buy Stoneridge Stock Online?
In order to purchase Stoneridge stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
